Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 11 04:00PM ET
25.53
Dollar change
+0.15
Percentage change
0.57
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y34.14% Shs Outstand Perf Week3.93%
SponsorBlackrock (iShares) ETF Type Tagsequity Return% 3Y-19.05% Total Holdings63 Perf Month3.89%
Fund Family Bond Type Tagshealthcare Return% 5Y0.16% AUM145.09M Perf Quarter5.78%
IndexNYSE FactSet Global Genomics and Immuno... Average Maturity Tagsgenomics Return% 10Y NAV% Perf Half Y6.89%
Index Weighting Commodity Type Tagspharmaceutical Return% SI NAV/sh Perf Year39.64%
Active/Passive Quant Type Tagsinnovation Flows% 1M0.00% 52W Range17.95 - 25.70 Perf YTD10.93%
Dividend TTM0.28 (1.10%) ESG Type Tags- Flows% 3M0.00% 52W High-0.67% Beta0.96
Dividend Ex-DateJun 11, 2024 Dividend Type Sector/Theme Flows% YTD-1.05% 52W Low42.20% ATR (14)0.34
Expense0.47% Structure Type Region Flows% 1Y RSI (14)68.20 Volatility1.28% 1.13%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume7.54 Prev Close25.38
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume24.60K Price25.53
SMA203.92% SMA504.14% SMA2006.66% Trades Volume185,399 Change0.57%
Sep-09-22 01:45PM
Mar-30-22 01:30PM
Feb-25-22 09:59PM
Dec-06-21 10:15AM
Oct-21-21 10:15AM
03:42PM Loading…
May-18-20 03:42PM
10:51AM
Dec-23-19 12:00PM
Dec-18-19 01:41PM
Nov-25-19 06:55PM
Nov-21-19 12:56PM
Nov-04-19 01:00PM
Oct-23-19 10:10AM
Sep-06-19 03:07PM
Sep-04-19 03:18PM
iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma IndexTM. The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.